ATE389387T1 - Verabreichungsform für pharmazeutische wirkstoffe - Google Patents
Verabreichungsform für pharmazeutische wirkstoffeInfo
- Publication number
- ATE389387T1 ATE389387T1 AT03732166T AT03732166T ATE389387T1 AT E389387 T1 ATE389387 T1 AT E389387T1 AT 03732166 T AT03732166 T AT 03732166T AT 03732166 T AT03732166 T AT 03732166T AT E389387 T1 ATE389387 T1 AT E389387T1
- Authority
- AT
- Austria
- Prior art keywords
- cell adhesion
- adhesion molecule
- active ingredients
- ncam
- pharmaceutical active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02014991A EP1380289A1 (de) | 2002-07-10 | 2002-07-10 | Verabreichungsform für pharmazeutische Agenzien |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE389387T1 true ATE389387T1 (de) | 2008-04-15 |
Family
ID=29724403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03732166T ATE389387T1 (de) | 2002-07-10 | 2003-07-08 | Verabreichungsform für pharmazeutische wirkstoffe |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060057193A1 (de) |
| EP (2) | EP1380289A1 (de) |
| JP (1) | JP2005535666A (de) |
| CN (1) | CN1665489B (de) |
| AT (1) | ATE389387T1 (de) |
| AU (1) | AU2003238331B2 (de) |
| CA (1) | CA2492089C (de) |
| DE (1) | DE60319830T2 (de) |
| WO (1) | WO2004006891A2 (de) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9203290A (es) * | 1983-09-19 | 1992-08-01 | Liposome Co Inc | Suministro localizado usando conjugados de fibronectina. |
| US5618916A (en) * | 1993-01-06 | 1997-04-08 | The Jewish Hospital Of St. Louis | Purified protein which functions as a mycobacterial receptor for fibronectin |
| US5756122A (en) * | 1995-06-07 | 1998-05-26 | Georgetown University | Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells |
| EP1214935A3 (de) * | 1996-10-11 | 2003-06-18 | Sequus Pharmaceuticals, Inc. | Fusogene Liposomenzusammensetzung und Verfahren |
| ATE466948T1 (de) * | 1997-03-11 | 2010-05-15 | Univ Minnesota | Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle |
| US6329501B1 (en) * | 1997-05-29 | 2001-12-11 | Auburn University | Methods and compositions for targeting compounds to muscle |
| WO2001028569A1 (en) * | 1999-10-15 | 2001-04-26 | Canji, Inc. | Targeted vectors |
| DE10056136A1 (de) * | 2000-11-07 | 2002-05-16 | Nemod New Modalities | Verwendung von Schwangerschaftsproteinen, Liposomen, nativen Muzin-Fragmenten und Mimikry-Verbindungen zur Behandlung und Prophylaxe von entzündlichen Erkrankungen, zur Verhinderung der Metastasierung und zur Prophylaxe von Tumorerkrankungen |
| JP2005500833A (ja) * | 2001-06-25 | 2005-01-13 | ブアズーボ・アンパルトセルスカブ | 腫瘍学薬物の革新 |
-
2002
- 2002-07-10 EP EP02014991A patent/EP1380289A1/de not_active Withdrawn
-
2003
- 2003-07-08 CA CA2492089A patent/CA2492089C/en not_active Expired - Lifetime
- 2003-07-08 EP EP03732166A patent/EP1523301B1/de not_active Expired - Lifetime
- 2003-07-08 WO PCT/CH2003/000453 patent/WO2004006891A2/en active IP Right Grant
- 2003-07-08 JP JP2004520262A patent/JP2005535666A/ja active Pending
- 2003-07-08 CN CN03816266.0A patent/CN1665489B/zh not_active Expired - Lifetime
- 2003-07-08 DE DE60319830T patent/DE60319830T2/de not_active Expired - Fee Related
- 2003-07-08 US US10/520,909 patent/US20060057193A1/en not_active Abandoned
- 2003-07-08 AT AT03732166T patent/ATE389387T1/de active
- 2003-07-08 AU AU2003238331A patent/AU2003238331B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1380289A1 (de) | 2004-01-14 |
| CN1665489A (zh) | 2005-09-07 |
| WO2004006891A2 (en) | 2004-01-22 |
| EP1523301B1 (de) | 2008-03-19 |
| US20060057193A1 (en) | 2006-03-16 |
| DE60319830T2 (de) | 2009-03-05 |
| CN1665489B (zh) | 2012-03-07 |
| CA2492089A1 (en) | 2004-01-22 |
| CA2492089C (en) | 2013-02-12 |
| EP1523301A2 (de) | 2005-04-20 |
| WO2004006891A3 (en) | 2004-02-26 |
| JP2005535666A (ja) | 2005-11-24 |
| DE60319830D1 (de) | 2008-04-30 |
| AU2003238331B2 (en) | 2009-11-19 |
| AU2003238331A1 (en) | 2004-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004105702A3 (en) | Foamable pharmaceutical compositions and methods for treating a disorder | |
| EP3118218A3 (de) | Fusionsproteine zur verabreichung in die blut-hirn-schranke | |
| ES2316356T3 (es) | Peptidos sinteticos complementarios y sus utilizaciones oftalmologicas. | |
| WO2005054279A8 (en) | Delivery peptides, their constructs with active agents and use | |
| WO2003047499A3 (en) | Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting | |
| EP2108390A3 (de) | Vorrichtung zur lokalen und/oder regionalen Abgabe von flüssigen Formulierungen von Therapiemitteln | |
| DE69433818D1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
| US20060178313A1 (en) | Use of a polypeptide for treatment of pruritus in animals | |
| WO2006073446A3 (en) | Peptide-mediated protein transduction into cells the hematopoietic lineage | |
| EP2292255A3 (de) | Stabile therapeutische Proteine | |
| WO2006010084A3 (en) | A system for delivering therapeutic agents into living cells and cell nuclei | |
| WO2002102311A3 (en) | Nanoparticles for treating targeted tissues and cells | |
| MX2007013007A (es) | Diazepanes farmaceuticamente activos. | |
| ATE389387T1 (de) | Verabreichungsform für pharmazeutische wirkstoffe | |
| WO2005087792A3 (en) | Materials and methods relating to the treatment of glioblastomas | |
| WO2002070741A3 (en) | Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna | |
| EP1632241A4 (de) | Mittel zur vorbeugung und/oder heilung von krankheiten in verbindung mit gewebezerstörung | |
| WO2001008708A3 (en) | Enhanced delivery via serpin enzyme complex receptor ligands | |
| JPH08325161A (ja) | 脊髄損傷に伴う神経障害の予防・治療剤 | |
| WO2006060664A3 (en) | Single-drug multi-ligand conjugates for targeted drug delivery | |
| WO2002047719A3 (en) | Survical promoting ncam binding and ncam ligand biding compounds | |
| ATE247984T1 (de) | Bioreduktive konjugate zur gezielten wirkstoffzufuhr | |
| Cooper | Complement and infectious agents | |
| WO2005062942A3 (en) | Novel oligonucleotides and treating cardiac disorders by using the same | |
| EP1627927A3 (de) | Verfahren, Systeme und Rechnerprogrammprodukte zur Erfassung der biologischen Wirkung und/oder Aktivität von Arzneimitteln, chemischen Substanzen und/oder pharmazeuitschen Verbindungen auf der Basis ihrer Effekte auf den Methylierungszustand der DNA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1523301 Country of ref document: EP |